NCT03392961View on ClinicalTrials.gov

Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

March 27, 2014

Primary Completion Date

July 1, 2014

Study Completion Date

July 1, 2014

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

IN-105 (Insulin Tregopil)

15 mg strength tablets for oral use used at a dose of 30 mg

OTHER

Placebo comparator

Placebo tablet for oral use

All Listed Sponsors
lead

Biocon Limited

INDUSTRY

NCT03392961 - Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD | Biotech Hunter | Biotech Hunter